Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Interest & Investment Income (2023 - 2025)

Upstream Bio has reported Interest & Investment Income over the past 3 years, most recently at $3.7 million for Q4 2025.

  • Quarterly results put Interest & Investment Income at $3.7 million for Q4 2025, down 28.01% from a year ago — trailing twelve months through Dec 2025 was $16.9 million (up 39.68% YoY), and the annual figure for FY2025 was $16.9 million, up 39.68%.
  • Interest & Investment Income for Q4 2025 was $3.7 million at Upstream Bio, down from $4.1 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for UPB hit a ceiling of $5.1 million in Q4 2024 and a floor of $1.3 million in Q1 2024.
  • Median Interest & Investment Income over the past 3 years was $3.3 million (2024), compared with a mean of $3.2 million.
  • Peak annual rise in Interest & Investment Income hit 274.64% in 2025, while the deepest fall reached 28.01% in 2025.
  • Upstream Bio's Interest & Investment Income stood at $1.5 million in 2023, then surged by 234.17% to $5.1 million in 2024, then fell by 28.01% to $3.7 million in 2025.
  • The last three reported values for Interest & Investment Income were $3.7 million (Q4 2025), $4.1 million (Q3 2025), and $4.4 million (Q2 2025) per Business Quant data.